<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.6.0 for Hugo" />
  

  
  












  
  










  







  
  

  
  
  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." />

  
  <link rel="alternate" hreflang="en-us" href="https://example.com/tag/cancers/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  
    
    <script src="/js/mathjax-config.js"></script>
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    

    
    
    
    
      
      
    
    
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
        <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml.js" integrity="" crossorigin="anonymous" async></script>
      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.7579f2ea081d74b9cb40a7d984071feb.css" />

  
  
  
  
  
  
  
    
    
    <link rel="stylesheet" href="/css/libs/chroma/github-light.min.css" title="hl-light" media="print" onload="this.media='all'" >
    <link rel="stylesheet" href="/css/libs/chroma/dracula.min.css" title="hl-dark" media="print" onload="this.media='all'" disabled>
  

  
  



  


  


  




  
  
  

  
  
    <link rel="alternate" href="/tag/cancers/index.xml" type="application/rss+xml" title="BM Sci-Tech Memento" />
  

  
  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  
  <link rel="icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://example.com/tag/cancers/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@wowchemy" />
    <meta property="twitter:creator" content="@wowchemy" />
  
  <meta property="og:site_name" content="BM Sci-Tech Memento" />
  <meta property="og:url" content="https://example.com/tag/cancers/" />
  <meta property="og:title" content="Cancers | BM Sci-Tech Memento" />
  <meta property="og:description" content="A highly-customizable Hugo documentation theme powered by Wowchemy website builder." /><meta property="og:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://example.com/media/icon_hu1efa9af2edf414d45fb59503b457ea16_13437_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta property="og:updated_time" content="2023-01-17T00:00:00&#43;00:00" />
    
  

  



  


  <title>Cancers | BM Sci-Tech Memento</title>

  
  
  
  











</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   "  >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.613040fe4f2c0f007b4dcb64404201cb.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">BM Sci-Tech Memento</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          

          

          
          
          
          

          
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/tool/"><span>Tools</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="/docs/"><span>Notes</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://pubmed.ncbi.nlm.nih.gov/" target="_blank" rel="noopener"><span>PubMed</span></a>
          </li>

          
          

          

          
          
          
            
              
            
          

          

          
          
          
          

          
            
              
              
            
            
          

          <li class="nav-item">
            <a class="nav-link " href="https://licore.netlify.app/" target="_blank" rel="noopener"><span>MII</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        

        
        
        <li class="nav-item">
          <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        
        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    
    
    

    












  

  
  
  
    
  
<div class="universal-wrapper pt-3">
  <h1>Cancers</h1>

  

  
</div>



<div class="universal-wrapper">
  

  
  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36650118/" >LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing</a>
    </div>

    
    <a href="/article/36650118/"  class="summary-link">
      <div class="article-style">
        Abstract
Background: The therapeutic value of targeted therapies in patients with lung cancer is reduced when tumours acquire secondary resistance after an initial period of successful treatment. However, the molecular events behind the resistance to targeted therapies in lung cancer remain largely unknown.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Tuesday, 17 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://onlinelibrary.wiley.com/doi/10.1002/ctm2.1129" target="_blank" rel="noopener">
    Clinical and Translational Medicine</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36650118/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36650118/" >
      <img src="/article/36650118/featured_hu44e3b1d5ef13dc496c21e4df81313d0a_165010_150x0_resize_q75_h2_lanczos.webp" height="82" width="150"
           alt="LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36642705/" >Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies</a>
    </div>

    
    <a href="/article/36642705/"  class="summary-link">
      <div class="article-style">
        Abstract
Enhancer of zeste homolog 2 (EZH2), an enzymatic subunit of PRC2 complex, plays an important role in tumor development and progression through its catalytic and noncatalytic activities. Overexpression or gain-of-function mutations of EZH2 have been significantly associated with tumor cell proliferation of triple-negative breast cancer (TNBC) and diffuse large B-cell lymphoma (DLBCL).
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 16 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41392-022-01240-3" target="_blank" rel="noopener">
    Signal Transduction and Targeted Therapy</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36642705/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36642705/" >
      <img src="/article/36642705/featured_hu0944f9bb2b3698b024a3621eee8d287d_105676_150x0_resize_q75_h2_lanczos.webp" height="88" width="150"
           alt="Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36646802/" >Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer</a>
    </div>

    
    <a href="/article/36646802/"  class="summary-link">
      <div class="article-style">
        Abstract
Despite standard-of-care treatment, more than 30% of patients with resectable colorectal cancer (CRC) relapse. Circulating tumor DNA (ctDNA) analysis may enable postsurgical risk stratification and adjuvant chemotherapy (ACT) treatment decision-making.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 16 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41591-022-02115-4" target="_blank" rel="noopener">
    Nature Medicine</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36646802/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36646802/" >
      <img src="/article/36646802/featured_hu89e660322cca5902df719ab5d6d188f2_146174_150x0_resize_q75_h2_lanczos.webp" height="83" width="150"
           alt="Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36646788/" >Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth</a>
    </div>

    
    <a href="/article/36646788/"  class="summary-link">
      <div class="article-style">
        Abstract
Impairment of the circadian clock is linked to cancer development. However, whether the circadian clock is modulated by oncogenic receptor tyrosine kinases remains unclear. Here we demonstrated that receptor tyrosine kinase activation promotes CK2-mediated CLOCK S106 phosphorylation and subsequent disassembly of the CLOCK–BMAL1 dimer and suppression of the downstream gene expression in hepatocellular carcinoma (HCC) cells.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 16 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41556-022-01061-0" target="_blank" rel="noopener">
    Nature Cell Biology</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36646788/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36646789/" >Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation</a>
    </div>

    
    <a href="/article/36646789/"  class="summary-link">
      <div class="article-style">
        Abstract
Defining drivers of tumour initiation can provide opportunities to control cancer progression. Here we report that lysophosphatidic acid receptor 4 (LPAR4) becomes transiently upregulated on pancreatic cancer cells exposed to environmental stress or chemotherapy where it promotes stress tolerance, drug resistance, self-renewal and tumour initiation.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Monday, 16 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41556-022-01055-y" target="_blank" rel="noopener">
    Nature Cell Biology</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36646789/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36641751/" >Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex</a>
    </div>

    
    <a href="/article/36641751/"  class="summary-link">
      <div class="article-style">
        Highlights
p53 associates with phosphorylated ERK2 through a hydrophobic interaction Mutant KRAS enables ERK2 to interact with p53 based on conformation change Trametinib disrupts the ERK2-p53 complex by blocking ERK2 phosphorylation Trametinib promotes PUMA transcription by recruiting p300/CBP to p53 protein Abstract
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Saturday, 14 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.cell.com/cell-reports/fulltext/S2211-1247%2822%2901876-9" target="_blank" rel="noopener">
    Cell Reports</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36641751/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36641751/" >
      <img src="/article/36641751/featured_hu5504787548362b18e612deb89153c996_107930_150x0_resize_q75_h2_lanczos.webp" height="150" width="150"
           alt="Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/35697349/" >Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer</a>
    </div>

    
    <a href="/article/35697349/"  class="summary-link">
      <div class="article-style">
        Abstract
Transcriptional reactivation of hTERT is the limiting step in tumorigenesis. While mutations in hTERT promoter present in 19% of cancers are recognized as key drivers of hTERT reactivation, mechanisms by which wildtype hTERT (WT-hTERT) promoter is reactivated, in majority of human cancers, remain unknown.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 11 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://academic.oup.com/nar/article/51/1/1/6605892" target="_blank" rel="noopener">
    Nucleic Acids Research</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/35697349/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/35697349/" >
      <img src="/article/35697349/featured_hu648d4e455e6327e78df5acec0ef2421b_39167_150x0_resize_q75_h2_lanczos.webp" height="104" width="150"
           alt="Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36627278/" >Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation</a>
    </div>

    
    <a href="/article/36627278/"  class="summary-link">
      <div class="article-style">
        Abstract
Lkb1 deficiency confers the Kras-mutant lung cancer with strong plasticity and the potential for adeno-to-squamous transdifferentiation (AST). However, it remains largely unknown how Lkb1 deficiency dynamically regulates AST. Using the classical AST mouse model (KrasLSL-G12D/+;Lkb1flox/flox, KL), we here comprehensively analyze the temporal transcriptomic dynamics of lung tumors at different stages by dynamic network biomarker (DNB) and identify the tipping point at which the Wnt signaling is abruptly suppressed by the excessive accumulation of reactive oxygen species (ROS) through its downstream effector FOXO3A.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 11 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41392-022-01227-0" target="_blank" rel="noopener">
    Signal Transduction and Targeted Therapy</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36627278/" target="_blank" rel="noopener">
    PubMed</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832009/" target="_blank" rel="noopener">
    PMC</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
    
    <a href="/article/36627278/" >
      <img src="/article/36627278/featured_hu6f277b9de2114bf867e38337bd0cc400_356922_150x0_resize_q75_h2_lanczos.webp" height="188" width="150"
           alt="Oxidative stress-triggered Wnt signaling perturbation characterizes the tipping point of lung adeno-to-squamous transdifferentiation" loading="lazy">
    </a>
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/article/36630483/" >Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models</a>
    </div>

    
    <a href="/article/36630483/"  class="summary-link">
      <div class="article-style">
        Abstract
Pancreatic and lung cancers frequently develop resistance to chemotherapy-induced cell apoptosis during the treatment, indicating that targeting nonapoptotic-related pathways, such as pyroptosis, can be an alternative cancer treatment strategy. Pyroptosis is a gasdermin-driven lytic programmed cell death triggered by inflammatory caspases when initiated by canonical or noncanonical pathways that has been recently seen as a potential therapeutic target in cancer treatment.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 11 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.science.org/doi/10.1126/scitranslmed.abl7895" target="_blank" rel="noopener">
    Science Translational Medicine</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36630483/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  
    













  


<div class="media stream-item view-compact">
  <div class="media-body">

    <div class="section-subheading article-title mb-0 mt-0">
      <a href="/review/36631716/" >Updated epidemiology of gastrointestinal cancers in East Asia</a>
    </div>

    
    <a href="/review/36631716/"  class="summary-link">
      <div class="article-style">
        Abstract
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence and one-third of cancer-related mortality. Although there has been much progress in screening colorectal cancer, the prognosis of other gastrointestinal cancers tends to be poor.
      </div>
    </a>
    

    <div class="stream-meta article-metadata">

      

      
        


<div class="article-metadata">

  
  

  
  <span class="article-date">
    
    
      
    
    Wednesday, 11 January 2023 
  </span>
  

  

  

  
  
  
  

  
  

</div>

      
    </div>

    
    <div class="btn-links">
      








  


















  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://www.nature.com/articles/s41575-022-00726-3" target="_blank" rel="noopener">
    Nature Reviews Gastroenterology & Hepatology</a>

  
  
  
    
  
  
  
  
  
    
  
  <a class="btn btn-outline-primary btn-page-header btn-sm" href="https://pubmed.ncbi.nlm.nih.gov/36631716/" target="_blank" rel="noopener">
    PubMed</a>


    </div>
    

  </div>
  <div class="ml-3">
    
    
  </div>
</div>

  

  
<nav class="mt-1">
  <ul class="pagination justify-content-center">
    
    
    <li class="page-item"><a class="page-link" href="/tag/cancers/page/2/">&raquo;</a></li>
    
  </ul>
</nav>


</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  












  

  

  

  
  






  
  <p class="powered-by copyright-license-text">
    Copyright © 2023 | Biomedist | All rights reserved.
  </p>
  




  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  


<script src="/js/vendor-bundle.min.d26509351aa0ff874abbee824e982e9b.js"></script>




  

  
  

  













  
  <script id="search-hit-fuse-template" type="text/x-template">
    <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
    </div>
  </script>
  
    <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
    <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
  












  
  
  
  
  
  
  







<script id="page-data" type="application/json">{"use_headroom":true}</script>



  <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>








  
  


<script src="/en/js/wowchemy.min.54dd6e4d8f2e4b1d098381b57f18dd83.js"></script>























</body>
</html>
